A new mandatory federal model aims to reduce the kidney transplant shortage by giving incentives for greater donor kidney ...
The most common adverse events reported with both treatments were mild to moderate gastrointestinal-related side effects.
Prior authorization requirements can be harmful to cancer patients and place additional burdens on medical practices, survey results suggest.
Therapeutic options to treat intermediate-risk and BCG-unresponsive bladder cancer, such as medications and ablative therapies, are expanding, and novel PET tracers enable improved diagnosis and ...
(HealthDay News) — Long-term sex hormone treatment in transgender individuals can lead to significant changes in body composition and risk factors for cardiovascular disease, according to a study ...
Three good practice statements include regularly testing serum iron studies, which can influence decision to use oral or IV iron treatment ...
Only 19% of patients were treated with oral and/or third-line therapies during six-year study; third-line therapy increased from 2013 to 2018 ...
(HealthDay News) — American seniors still pay more for health care than their counterparts in most other wealthy countries do, despite coverage by Medicare, a new study finds. They are also more ...
Prices of cancer drugs increase “substantially” after they are launched in the United States, according to researchers.
Glucagon-like peptide-1 receptor agonists (GLP-1 RA) significantly reduce the risk for clinically meaningful chronic kidney disease (CKD) progression and major adverse cardiovascular events (MACE) in ...
(HealthDay News) — President-elect Donald Trump has tapped Dr. Jay Bhattacharya, a Stanford health economist and critic of pandemic lockdowns and vaccine mandates, to lead the nation’s largest medical ...
Authors say findings may be due to relative excess of thyroid hormone even when treatment is targeted to reference range goals ...